comparemela.com

Latest Breaking News On - Deciphera pharmaceuticals company profile - Page 1 : comparemela.com

Deciphera Pharmaceuticals (NASDAQ:DCPH) Sets New 12-Month High at $25.59

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Free Report)’s stock price hit a new 52-week high during trading on Monday . The company traded as high as $25.59 and last traded at $25.58, with a volume of 366347 shares changing hands. The stock had previously closed at $25.57. Analysts Set New Price Targets A number of […]

United-states
Charles-schwab-investment-management-inc
Deciphera-pharmaceuticals-price-performance
Institutional-trading-of-deciphera-pharmaceuticals
Deciphera-pharmaceuticals
Deciphera-pharmaceuticals-inc
Principal-financial-group-inc
Jefferies-financial-group
Deciphera-pharmaceuticals-company-profile
Deutsche-bank
Jpmorgan-chase-co

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Receives $24.17 Average Price Target from Brokerages

Shares of Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Free Report) have been assigned a consensus recommendation of “Hold” from the ten brokerages that are currently covering the firm, Marketbeat.com reports. Seven equities research analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average twelve-month […]

United-states
Deciphera-pharmaceuticals-inc
Deciphera-pharmaceuticals-stock-performance
Deciphera-pharmaceuticals
Nasdaq
Institutional-trading-of-deciphera-pharmaceuticals
Barclays
News-ratings-for-deciphera-pharmaceuticals-daily
Deutsche-bank
Deciphera-pharmaceuticals-company-profile
Analyst-recommendations-for-deciphera-pharmaceuticals

Deciphera Pharmaceuticals (NASDAQ:DCPH) Sees Large Volume Increase

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Free Report) saw unusually-high trading volume on Tuesday . Approximately 1,116,913 shares traded hands during trading, a decline of 1% from the previous session’s volume of 1,129,558 shares.The stock last traded at $25.30 and had previously closed at $25.28. Analysts Set New Price Targets DCPH has been the topic […]

China
United-states
Deciphera-pharmaceuticals
Deciphera-pharmaceuticals-inc
Institutional-trading-of-deciphera-pharmaceuticals
Nasdaq
Quest-partners
News-ratings-for-deciphera-pharmaceuticals-daily
Deciphera-pharmaceuticals-stock-performance
Jefferies-financial-group
Deciphera-pharmaceuticals-company-profile

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Receives Consensus Recommendation of "Moderate Buy" from Brokerages
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states
Stifel-nicolaus
Dimensional-fund-advisors
Nasdaq
Goldman-sachs-group-inc
Deciphera-pharmaceuticals
Frazier-life-sciences-management
Jpmorgan-chase-co
News-ratings-for-deciphera-pharmaceuticals-daily
Institutional-investors-weigh-in-on-deciphera-pharmaceuticals
Jefferies-financial-group
Deciphera-pharmaceuticals-stock-performance

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Receives $22.60 Consensus Target Price from Analysts

Shares of Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Free Report) have earned a consensus rating of “Moderate Buy” from the six brokerages that are presently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average 12 month […]

United-states
Stifel-nicolaus
Matthewl-sherman
Deerfield-management-companylp-series
Deciphera-pharmaceuticals-stock-performance
Panagora-asset-management-inc
News-ratings-for-deciphera-pharmaceuticals-daily
Nasdaq
Deciphera-pharmaceuticals-company-profile
Insider-transactions-at-deciphera-pharmaceuticals
Jpmorgan-chase-co
Institutional-investors-weigh-in-on-deciphera-pharmaceuticals

vimarsana © 2020. All Rights Reserved.